Bob Storey

Robert (Bob) Storey is Managing Director of The MVR Company, which focuses on the assessment and creation of new ventures, with an emphasis on medical technologies. He is also the Managing Partner of The LaunchPort™ in Baltimore, Maryland, an innovative manufacturing accelerator for early stage medical device companies entering the regulatory approval process and preparing for commercial adoption. He is Chairman and Board Member for a number of early stage life sciences companies.

Mr. Storey is currently on assignment as a Portfolio Executive for NIH’s Rapid Acceleration of Diagnostics (RADx) Program dealing with the US’s SARS-CoV-2 testing crisis.

He is currently serving on the External Advisory Board for the Johns Hopkins Center for Biomedical Innovation and Design, the Strategic Advisory Board for Johns Hopkins Laboratory for Computational Sensing and Robotics, the JHU Applied Physics Lab Technology Commercialization Panel, the Investment Review Committees for the Bisciotti Fund, and is the Johns Hopkins advocate for medical device and engineering investment submissions to the Maryland Innovation Initiative.

He is appointed to the State of Maryland’s Life Sciences Advisory Board and has been active in efforts of collaboration between the FDA, Payors, Device companies and Providers to develop a high value medical device demonstration hub in Maryland. He is the Medical Device expert for the National Institute of Health’s I-Corps @ NIH™ program, is a Nationally Certified Instructor for the National Science Foundation’s I-Corps™ and was a founding instructor in the development of the NIH NCATS/CTSI I-Corps program. In addition to his roles at the national level, he is the principal instructor for life science lean innovation programs at Johns Hopkins University and the University of Miami Biomedical Engineering/Miller School of Medicine. He has led international cohorts in the Lean Start-up area in Asia/Pacific, Middle East, South America and Africa.

After earning degrees in chemical engineering and chemistry at the University of Arkansas, Mr. Storey joined Exxon Corporation in Houston, where he worked in performance materials technology, business planning, mergers, and acquisitions for close to 15 years. He was an advisor in Exxon’s Corporate Controller organization, held Sales and Marketing management positions, and crafted the formation of Exxon Chemical’s international joint venture with Mitsubishi Petrochemical. Mr. Storey left Exxon to become General Manager of a privately held engineering company in Maryland. He led the company through a successful sale to Clariant Corporation of Switzerland, where he served as Vice President of Clariant’s Performance Products division.

Following Clariant, Mr. Storey led Vapotherm, Inc. (NYSE: VAPO), a medical device company that specialized in non-invasive respiratory devices, as founding President and CEO. While with the firm for over a dozen years, he received the U.S Commerce Department’s Export Achievement Award, the Maryland World Trade Center International Leadership Award, and Deloitte’s Technology National Fast 500 award four times.